Product
GS-6212
1 clinical trial
1 indication
Indication
HIV-1 infectionClinical trial
An Umbrella Phase 1b, Open-label, Multi-Cohort Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Novel Antiretrovirals in Participants With HIV-1Status: Active (not recruiting), Estimated PCD: 2027-03-01